Figure 2 NFYAv1, but not NFYAv2, is associated with poor prognosis in patients with HCC(A, B) Comparison of NFYAv1 and NFYAv2 isoform expression percentage (A) and relative expression (B) in normal liver tissues in GTEx (n=110) and HCC tissues in TCGA (n=359). (C–F) K-M analysis for PFS (C, D) and DSS (E, F) comparison was performed. Patients with primary HCC in TCGA were classified into 2 groups by the median NFYAv2 (C, E) or NFYAv1 (D, F) expression. The log-rank test was performed to evaluate the survival difference. ***, P<0.001.